Anal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019 On 6th December 2014
Summary The industry analysis specialist, has released its new report, “Anal Cancer Therapeutics Pipeline Assessment and Market Forecasts to 2019�. The report is an essential source of information and analysis on the global Anal Cancer Therapeutics market. The report identifies the key trends shaping and driving the global Anal Cancer Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Anal Cancer Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
You can buy this Report @ http://www.jsbmarketresearch.com/healthcareEmail ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
medical/r-anal-cancer-therapeutics-pipeline-assessment-and-market-forecasts135239 Scope The report provides information on the key drivers and challenges of the Anal Cancer Therapeutics market. Its scope includes - Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Anal Cancer Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019. - Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes. - Analysis of the current and future competition in the seven key countries Anal Cancer Therapeutics market. - Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. - Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Anal Cancer Therapeutics market. - Analysis of key recent licensing and partnership agreements in Anal Cancer Therapeutics market
Reasons to buy The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global Anal Cancer Therapeutics market. Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Anal Cancer Therapeutics market in future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. - What’s the next big thing in the global Anal Cancer Therapeutics market landscape? – Identify, understand and capitalize
Other industries we cover: • • • • • • • • •
Advertising and Media Automotive and Parts Consumer Goods Healthcare and Medical Finance and Banking Food and Beverages Travel and Tourism Textiles and Clothing SWOT Analysis
Discounts on Market Research Reports till 31st December, 2014 For more inquiries, contact at +91 - 998 729 5242 / contact@jsbmarketresearch.com Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Table of Content 2 Anal Cancer Therapeutics - Introduction 2.1 Overview 2.2 Epidemiology 2.3 Etiology and Pathophysiology 2.4 Risk Factors for Anal Cancer 2.5 Symptoms 2.6 Diagnosis 2.6.1 Physical Exam and History 2.6.2 Endoscopy 2.6.3 Biopsy 2.6.4 Ultrasound 2.6.5 Digital Rectal Examination (DRE) 2.6.6 CT (Computerized Tomography) Scan 2.6.7 Human Papillomavirus Test 2.6.8 Other Recent Methods to Detect HPV Infections 2.7 Staging of Anal Cancer 2.8 Treatment for Patients with Anal Cancer 2.8.1 Surgery 2.8.2 Radiation Therapy 2.8.3 Chemotherapy 2.8.4 Limitations of Current HPV Vaccines 2.9 Treatment by Stage of the Disease 2.10 GlobalData Pipeline Report Guidance 3 Anal Cancer Therapeutics - Market Characterization 3.1 Anal Cancer Therapeutics Market Size (2006-2011) - Global 3.2 Anal Cancer Therapeutics Market Forecast (2011-2019) - Global 3.3 Anal Cancer Therapeutics Market Size (2006-2011) - The US 3.4 Anal Cancer Therapeutics Market Forecast (2011-2019) - The US 3.5 Anal Cancer Therapeutics Market Size (2006-2011) - The UK 3.6 Anal Cancer Therapeutics Market Forecast (2011-2019) - The UK 3.7 Anal Cancer Therapeutics Market Size (2006-2011) - France 3.8 Anal Cancer Therapeutics Market Forecast (2011-2019) - France 3.9 Anal Cancer Therapeutics Market Size (2006-2011) - Germany Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
3.10 Anal Cancer Therapeutics Market Forecast (2011-2019) - Germany 3.11 Anal Cancer Therapeutics Market Size (2006-2011) - Italy 3.12 Anal Cancer Therapeutics Market Forecast (2011-2019) - Italy 3.13 Anal Cancer Therapeutics Market Size (2006-2011) - Spain 3.14 Anal Cancer Therapeutics Market Forecast (2011-2019) - Spain 3.15 Anal Cancer Therapeutics Market Size (2006-2011) - Japan 3.16 Anal Cancer Therapeutics Market Forecast (2011-2019) - Japan 3.17 Drivers and Barriers for the Anal Cancer Therapeutics Market 3.17.1 Drivers for the Anal Cancer Therapeutics Market 3.17.2 Barriers for the Anal Cancer Therapeutics Market 3.18 Opportunity and Unmet Need 3.18.1 Opportunity and Unmet Need for the Anal Cancer Therapeutics Market 3.19 Key Takeaway 4 Anal Cancer Therapeutics Market - Competitive Assessment 4.1 Overview 4.2 Strategic Competitor Assessment 4.2.1 Competitor Assessment within Different Categories Employed in Anal Cancer Treatment 4.3 Product Profile for Recommended Regimens for Anal Cancer Therapeutics Market 4.3.1 5- Fluorouracil in Combination with Mitomycin 4.3.2 5- FU in Combination with Cisplatin 4.3.3 Prophylactic Vaccine Used for Anal Cancer: Gardasil 4.4 Key Takeaway 5 Anal Cancer Therapeutics - Pipeline Assessment 5.1 Overview 5.2 Strategic Pipeline Assessment 5.3 Anal Cancer Therapeutics - Pipeline by Phases of Development 5.3.1 Anal Cancer Therapeutics - Phase II Pipeline 5.3.2 Anal Cancer Therapeutics - Phase I Pipeline 5.3.3 Anal Cancer Therapeutics - Preclinical Pipeline 5.4 Anal Cancer Therapeutics- Pipeline by Mechanism of Action 5.4.1 Technology Trends Analytic Framework 5.5 Molecule Profile for Drugs under Clinical Development 5.5.1 Panitumumab in Combination with mitomicin C, 5-FU and Radiation Therapy 5.5.2 TheraCIM (Nimotuzumab) in Combination with Radiation Therapy 5.6 Key Takeaway Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
6 Anal Cancer Therapeutics - Clinical Trials Mapping 6.1 Clinical Trials by Country (US, EU5 and Japan) 6.2 Clinical Trials by Phase 6.3 Clinical Trials by Status 6.4 Overall Sponsors 6.5 Prominent Sponsors 7 Anal Cancer Therapeutics - Strategic Assessment 7.1 Anal Cancer Therapeutics - Implications for Future Market Competition 8 Anal Cancer Therapeutics - Future Players 8.1 Introduction 8.2 Company Profiles 8.2.1 YM BioSciences Inc. (YM BioSciences) 8.2.2 PDS Biotechnology Corporation (PDS) 9 Anal Cancer Therapeutics - Appendix 9.1 Market Definitions 9.2 Abbreviations 9.3 Methodology 9.3.1 Coverage 9.3.2 Secondary Research 9.3.3 Forecasting 9.3.4 Primary Research 9.3.5 Expert Panel Validation 9.4 Contact Us 9.5 Disclaimer 9.6 Bibliography List Of Tables Table 1: Anal Cancer Therapeutics - Incidence Rate Table 2: Definitions of TNM Table 3: TNM Classification and Stages of Anal Cancer Table 4: Description of Prophylactic Anal Cancer Vaccine Table 5: Anal Cancer Therapeutics Market, Seven Major Markets, Revenue ($m), 2006-2011 Table 6: Anal Cancer Therapeutics Market, Major Markets, Forecast ($m), 2011-2019 Table 7: Anal Cancer Therapeutics Market, The US, Revenue ($m), 2006-2011 Table 8: Anal Cancer Therapeutics Market, The US, Forecast ($m), 2011-2019 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Table 9: Anal Cancer Therapeutics Market, The UK, Revenue ($m), 2006-2011 Table 10: Anal Cancer Therapeutics Market, The UK, Forecast ($m), 2011-2019 Table 11: Anal Cancer Therapeutics Market, France, Revenue ($m), 2006-2011 Table 12: Anal Cancer Therapeutics Market, France, Forecast ($m), 2011-2019 Table 13: Anal Cancer Therapeutics Market, Germany, Revenue ($m), 2006-2011 Table 14: Anal Cancer Therapeutics Market, Germany, Forecast ($m), 2011-2019 Table 15: Anal Cancer Therapeutics Market, Italy, Revenue ($m), 2006-2011 Table 16: Anal Cancer Therapeutics Market, Italy, Forecast ($m), 2011-2019 Table 17: Anal Cancer Therapeutics Market, Spain, Revenue ($m), 2006-2011 Table 18: Anal Cancer Therapeutics Market, Spain, Forecast ($m), 2011-2019 Table 19: Anal Cancer Therapeutics Market, Japan, Revenue ($m), 2006-2011 Table 20: Anal Cancer Therapeutics Market, Japan, Forecast ($m), 2011-2019 Table 21: Gardasil Approvals and Fillings Table 22: Anal Cancer Therapeutics - Phase II Pipeline, 2011 Table 23: Anal Cancer Therapeutics - Phase I Pipeline, 2011 Table 24: Anal Cancer Therapeutics - Preclinical Pipeline, 2011 Table 25: Anal Cancer - Clinical Trials by Country, 2011 Table 26: Anal Cancer - Clinical Trials by Phase, 2011 Table 27: Anal Cancer - Clinical Trials by Status, 2011 Table 28: Anal Cancer - Overall Sponsors, 2011 Table 29: Anal Cancer - Prominent Sponsors, 2011
List Of Figures Figure 1: Human Papillomavirus Infection and Replication in Anogenital Epithelial Cells Figure 2: Anal Cytology Screening for Anal Squamous Intraepithelial Lesions Figure 3: Stages of Anal Cancer Figure 4: Anal Cancer Surgery with Colostomy, 2011 Figure 5: Chemotherapy Regimens for Anal Cancer Figure 6: Anal Cancer Treatment by Stage of the Disease, 2011 Figure 7: Anal Cancer Treatment Protocols - Chemo-radiation Therapy or Chemotherapy by Stage, 2011 Figure 8: Anal Cancer Therapeutics Market, Seven Major Markets, Revenue ($m), 2006-2011 Figure 9: Anal Cancer Therapeutics, Market Share ($m), 2011 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Figure 10: Anal Cancer Therapeutics Market, Major Markets, Forecast ($m), 2011-2019 Figure 11: Anal Cancer, Seven Major Markets, Market Share ($m), 2019 Figure 12: Anal Cancer Therapeutics Market, The US, Revenue ($m), 2006-2011 Figure 13: Anal Cancer Therapeutics Market, The US, Forecast ($m), 2011-2019 Figure 14: Anal Cancer Therapeutics Market, The UK, Revenue ($m), 2006-2011 Figure 15: Anal Cancer Therapeutics Market, The UK, Forecast ($m), 2011-2019 Figure 16: Anal Cancer Therapeutics Market, France, Revenue ($m), 2006-2011 Figure 17: Anal Cancer Therapeutics Market, France, Forecast ($m), 2011-2019 Figure 18: Anal Cancer Therapeutics Market, Germany, Revenue ($m), 2006-2011 Figure 19: Anal Cancer Therapeutics Market, Germany, Forecast ($m), 2011-2019 Figure 20: Anal Cancer Therapeutics Market, Italy, Revenue ($m), 2006-2011 Figure 21: Anal Cancer Therapeutics Market, Italy, Forecast ($m), 2011-2019 Figure 22: Anal Cancer Therapeutics Market, Spain, Revenue ($m), 2006-2011 Figure 23: Anal Cancer Therapeutics Market, Spain, Forecast ($m), 2011-2019 Figure 24: Anal Cancer Therapeutics Market, Japan, Revenue ($m), 2006-2011 Figure 25: Anal Cancer Therapeutics Market, Japan, Forecast ($m), 2011-2019 Figure 26: Anal Cancer Therapeutics Market, Drivers and Barriers, 2011 Figure 27: Anal Cancer Therapeutics Market, Drivers and Barriers and Its Influence, 2011 Figure 28: Opportunity and Unmet Need for Anal Cancer Therapeutics Market, 2011 Figure 29: Anal Cancer Therapeutics Market - Strategic Competitor Assessment, 2011 Figure 30: Anal Cancer Therapeutics - Pipeline by Phase of Development, (%), 2011 Figure 31: Anal Cancer Therapeutics - Pipeline by Phase of Development, 2011 Figure 32: Anal Cancer Therapeutics- Clinical Pipeline by Mechanism Of Action, 2011 Figure 33: Anal Cancer Therapeutics- Technology Trends Analytics Framework, 2011 Figure 34: Anal Cancer - Clinical Trials by Country, 2011 Figure 35: Anal Cancer - Clinical Trials by Phase, 2011 Figure 36: Anal Cancer - Clinical Trials by Status, 2011 Figure 37: Anal Cancer - Overall Sponsors, 2011 Figure 38: Anal Cancer - Prominent Sponsors, 2011 Figure 39: Implications for Future Market Competition in Anal Cancer Therapeutics Market, 2011 Figure 40: Anal Cancer Therapeutics - Pipeline by Company, 2011 Figure 41: GlobalData Market Forecasting Model
Report Price: Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Licence Type
Price
$ 3995
Site Licence
$ 7990
Enterprise Wide Licence
$ 11985
Related Reports: Peptic Ulcer Therapeutics- Pipeline Assessment and Market Forecasts to 2018 Portal Hypertension Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Hepatic Encephalopathy - Pipeline Assessment and Market Forecasts to 2019 Diabetic Gastroparesis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Pancreatitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Aplastic Anemia Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Polycythemia Vera Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Growth Hormone Deficiency (GHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
You can order this report by calling on +91 - 998 7295 242 or mail us your contact details at contact@jsbmarketresearch.com About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is oneEmail ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
stop-shop for all information related to market research for any sector of the industry. Along with providing in-depth analysis though reports, JSB market research also provides regular updates of the market though newsletters. Our reports are a well-researched work of market researchers with an extensive knowledge and a good level of market experience.
To know more on Anal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019 http://www.jsbmarketresearch.com/healthcare-medical/r-anal-cancertherapeutics-pipeline-assessment-and-market-forecasts-135239
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/